Acorah Software Products - Accounts Production 16.6.950 false true 31 March 2024 1 November 2022 false 1 April 2024 31 March 2025 31 March 2025 12277919 Mr Leo De Watts iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12277919 2024-03-31 12277919 2025-03-31 12277919 2024-04-01 2025-03-31 12277919 frs-core:CurrentFinancialInstruments 2025-03-31 12277919 frs-core:FurnitureFittings 2025-03-31 12277919 frs-core:FurnitureFittings 2024-04-01 2025-03-31 12277919 frs-core:FurnitureFittings 2024-03-31 12277919 frs-core:ShareCapital 2025-03-31 12277919 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 12277919 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12277919 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 12277919 frs-bus:SmallEntities 2024-04-01 2025-03-31 12277919 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 12277919 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12277919 frs-core:UnlistedNon-exchangeTraded 2025-03-31 12277919 frs-core:UnlistedNon-exchangeTraded 2024-03-31 12277919 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 12277919 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 12277919 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-03-31 12277919 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 12277919 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 12277919 frs-bus:Director1 2024-04-01 2025-03-31 12277919 frs-countries:EnglandWales 2024-04-01 2025-03-31 12277919 2022-10-31 12277919 2024-03-31 12277919 2022-11-01 2024-03-31 12277919 frs-core:CurrentFinancialInstruments 2024-03-31 12277919 frs-core:ShareCapital 2024-03-31 12277919 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 12277919
Fx Health Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 12277919
31 March 2025 31 March 2024
as restated
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 40 49
Investments 5 312,165 233,447
312,205 233,496
CURRENT ASSETS
Debtors 6 138,212 102,367
Cash at bank and in hand 785 607
138,997 102,974
Creditors: Amounts Falling Due Within One Year 7 (227,338 ) (263,108 )
NET CURRENT ASSETS (LIABILITIES) (88,341 ) (160,134 )
TOTAL ASSETS LESS CURRENT LIABILITIES 223,864 73,362
NET ASSETS 223,864 73,362
CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Profit and Loss Account 222,864 72,362
SHAREHOLDERS' FUNDS 223,864 73,362
Page 1
Page 2
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Leo De Watts
Director
29th December 2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Fx Health Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12277919 . The registered office is 20-22 Wenlock Road, London, N1 7GU.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 20% reducing balance
2.3. Financial Instruments
Investments in equity instruments are measured at fair value with changes in fair value recognised in profit or loss where the fair value can be measured reliably. As there is no active market for these shares, fair value is determined using the most recent share price established during the companies' periodic liquidity events. These investments are classified as Level 3 in the fair value hierarchy as they are valued using inputs that are not based on observable market data.
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
Page 3
Page 4
4. Tangible Assets
Fixtures & Fittings
£
Cost or Valuation
As at 1 April 2024 110
As at 31 March 2025 110
Depreciation
As at 1 April 2024 61
Provided during the period 9
As at 31 March 2025 70
Net Book Value
As at 31 March 2025 40
As at 1 April 2024 49
5. Investments
Unlisted
£
Cost or Valuation
As at 1 April 2024 233,447
Revaluations 78,718
As at 31 March 2025 312,165
Provision
As at 1 April 2024 -
As at 31 March 2025 -
Net Book Value
As at 31 March 2025 312,165
As at 1 April 2024 233,447
The company holds investments in two UK-based private holding companies: Octopus Group Holdings Limited ("OGHL") and OE Holdco Limited ("OEHL"). These investments arose from the demerger of Octopus Capital Limited on 2 November 2022, at which date the company received 7,856 shares in each entity in exchange for its holding in Octopus Capital Limited.
The company holds further investments in a private limited company amounting to 2,000 shares valued at £20,000.
6. Debtors
31 March 2025 31 March 2024
as restated
£ £
Due within one year
Other debtors 138,212 102,367
Page 4
Page 5
7. Creditors: Amounts Falling Due Within One Year
31 March 2025 31 March 2024
as restated
£ £
Trade creditors 1 -
Other loans - 44,255
Other creditors 227,337 217,847
Taxation and social security - 1,006
227,338 263,108
8. Share Capital
31 March 2025 31 March 2024
as restated
£ £
Allotted, Called up and fully paid 1,000 1,000
Page 5